From Information to Innovation

The member companies of the IGES Group contribute to designing infrastructures: for healthcare, transport, housing and education. For more than 40 years we have delivered research and consulting services – analyses, expert opinions, studies, concepts and strategies – in Europe.

6,000

Projects

200

Employees

15

Companies

7

Countries

Data

the basis for all our work

with in-house

  • Biometrics & Statistics
  • Software development
  • Data Science & Big Data
  • IT & Data Security
Pandemie Monitor

Updated Guide

IGES Institut

Update: new guide provides information on the European pricing and reimbursement system for innovative pharmaceutical products

Due to high demand, IGES experts have reissued the successful guide on the European reimbursement and pricing systems for pharmaceutical products. It also provides updated information on the harmonisation of the benefit assessment of new therapies at EU level. » Details

IGES Italy Pharma Consulting

IGES Institut

IGES founds new subsidiary in Italy: IGES Italy Pharma Consulting

The IGES Group has opened another location in Europe. With the founding of IGES Italy Pharma Consulting, the Group also established a presence in Italy at the beginning of the year. » Details

ISPOR Europe 2024

IGES Institut

IGES at the health economics conference ISPOR Europe 2024 in Barcelona

The IGES Group will once again be present at the European conference of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Experts will present analyses on the benefit assessment in Germany. » Details

BIO-Europe 2024

IGES Institut

Panel at BIO-EUROPE: Start early, seek advice, talk to the HTA Agencies

EU-HTA will start in time in 69 days. Fundamental implementing acts adopted – preparations under time pressure but will finish in time. » Details

BIO 2024 International Convention

IGES Institut

BIO 2024 International Convention

The panel “Europe's Policy Environment and the Impact on the Biotech Sector” analyzed the proposed revisions to the General Pharmaceutical Legislation (GPL) , including changes to regulatory data protection. » Details

IGES

Companies of the IGES Group

Business Area

Public Infrastructures in Germany, Austria, Switzerland

  • Health
  • Transport
  • Education
  • Housing

Business Area

LifeScience - Access to Europe

  • Medtech
  • Pharmaceuticals
  • Digital Health